Q1 Earnings Forecast for SAGE Issued By HC Wainwright
Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) – Analysts at HC Wainwright issued their Q1 2026 EPS estimates for Sage Therapeutics in a research note issued on Wednesday, April 30th. HC Wainwright analyst D. Tsao expects that the biopharmaceutical company will post earnings per share of ($0.82) for the quarter. HC Wainwright has a “Neutral” […]
Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) – Analysts at HC Wainwright issued their Q1 2026 EPS estimates for Sage Therapeutics in a research note issued on Wednesday, April 30th. HC Wainwright analyst D. Tsao expects that the biopharmaceutical company will post earnings per share of ($0.82) for the quarter. HC Wainwright has a “Neutral” […]
